|
at 05:11 |
|
|
Results from study NIT-110 with NT-I7 and CPI combination treatment show median overall survival (mOS) improvements over standard of care treatment in pancreatic cancer and MSS colorectal cancerCorrelative analysis identified potentially predictive...
|
|
at 05:10 |
|
|
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, today announced it has been selected for Innovate UK's Global Incubator Programme in Houston, US. The programme, which is focused on...
|
|
at 05:00 |
|
|
In response to the recent position statement by the International Federation of Sports Medicine (FIMS) regarding the Enhanced Games,...
|
|
at 05:00 |
|
|
QRL-204 is a splice-switching ASO generated through QurAlis' FlexASOtm Platform; represents Lilly's first program targeting UNC13A in ALS and FTD
Parties to also collaborate to leverage QurAlis' ALS and ASO development expertise to advance QRL-204...
|
|
at 04:55 |
|
|
PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting Boehringer Ingelheim's ambition to...
|
|
at 04:00 |
|
|
DB HiTek, a leading foundry specialist in South Korea, is enhancing its global shutter and single-photon avalanche diode (SPAD) process technologies, which are highly utilized in the automotive,...
|
|
|
